Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13705-13717
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13705
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13705
Figure 12 Representative polyacrylamide gel autoradiograph employed in a typical ribonuclease protection assay of endogenous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 mRNA in pancreatic carcinoma cell line Panc1, stable transfected by pcDNA3.
1(+) vector (Panc1 cells) or by dominant/negative 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (Panc1 + dnPFKFB-3) in normoxic (N) condition and after treatment of Panc1 cells with dimethyloxalylglycine, inhibitor of prolyl hydroxylase (I; 1 mmol/L for 6 h). The 18S rRNA antisense probe was used as control of analyzed RNA quantity[89]. PFKFB: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
- Citation: Minchenko OH, Tsuchihara K, Minchenko DO, Bikfalvi A, Esumi H. Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells. World J Gastroenterol 2014; 20(38): 13705-13717
- URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13705.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13705